Current through Register Vol. 47, No. 12, March 26, 2025
Drugs and medications are permitted to be used only in
accordance with the following provisions.
(a) The following substances are permitted to
be used at any time up to race time:
(1)
topical applications (such as antiseptics, ointments, salves, DMSO leg rubs,
leg paints and liniments) that may contain antibiotics but do not contain
benzocaine, steroids or other drugs; and
(2) antibiotics, vitamins, electrolytes, and
other food supplements so long as they are administered orally and so long as
they do not contain any other drug or by their nature, exhibit drug-like
actions or properties.
(b)
Eligibility for the administration
of furosemide.
(1) The administration
of furosemide is permissible to a horse that has qualified for such use by any
of the following means:
(i) the horse has bled
visibly during a race or a workout, as determined by the association
veterinarian; or
(ii) the horse has
bled during a race or workout, as determined by an attending veterinarian based
upon such veterinarian's clinical assessment of the horse, which may or may not
include an endoscopic examination after the race or workout; or
(iii) the horse has been qualified by the
State veterinarian or a veterinarian employed by the racetrack for the
administration of furosemide in another racing jurisdiction; or
(iv) the horse has raced on furosemide in
such horse's last race in a jurisdiction with rules substantially similar to
New York State.
(2) If it
is determined that a horse has qualified pursuant to paragraph (1) of this
subdivision, and the owner or trainer elects to make the horse eligible for the
administration of furosemide, the horse shall be placed on a list, to be
maintained by the association veterinarian, of horses that have bled and shall
not be permitted to race for the following periods of time:
(i) 1st time - 10 days after such episode of
bleeding;
(ii) 2nd time - 30 days
after such episode of bleeding;
(iii) 3rd time - 90 days after such episode
of bleeding; and
(iv) 4th time -
one year after such episode of bleeding. Such list shall be made available to
the public for inspection.
(3) Eligibility to race on furosemide. For a
horse to be eligible to race on furosemide, the trainer of that horse must file
satisfactory documentation of eligibility pursuant to this rule with the
association veterinarian on or before time of entry.
(4) Removal from the furosemide list. A horse
that has been eligible for the administration of furosemide may be removed from
the list, upon authorization from the stewards. The state steward may remove a
horse from the list for the limited purpose of allowing the horse to compete in
a race whose conditions forbid the administration of furosemide on race
day.
(5) Reinstatement to
furosemide list. After removal from the furosemide list, a horse may be
reinstated for the administration of furosemide if:
(i) the horse again meets the requirements
set forth in paragraph (1) of this subdivision; or
(ii) the state steward at the request of the
trainer after the race and without requiring the horse to meet the requirements
set forth in paragraph (1) of this subdivision, reinstates a horse to the list
following a removal that occurred pursuant to paragraph (4) of this
subdivision. Such horse shall not be permitted to race for the applicable time
period set forth in paragraph (2) of this subdivision.
(6) Administration of furosemide. For the
purposes of this subdivision, furosemide shall be administered only in the
following manner:
(i) A single intravenous
(IV) injection of no less than 150 milligrams (3cc) and no more than 500
milligrams (10cc) may be administered on the grounds of a licensed or
franchised racing association or corporation during the time period from four
to four and one-half hours before the scheduled post time of the race in which
the horse is to compete.
(ii) The
administration shall be made by a veterinarian who is approved by the
commission and who does not perform other equine veterinary work for an owner
or trainer who participates at such race meeting, except for urgent veterinary
care in the capacity of a track veterinarian made available by the racetrack
operator.
(7)
Ineligibility to start. Any horse, that is eligible for the administration of
furosemide must be present on the grounds of the racing association or
corporation no less than four hours prior to scheduled post time of the race in
which the horse is scheduled to compete. A horse that is not present at least
four hours prior to post time or that has not received the administration of
furosemide pursuant to this subdivision shall be ineligible to start.
(c) The following substances may
be administered by any means except by joint injection until 24 hours before
the scheduled post time of the race in which the horse is to compete:
(2) sulfa-expectorants
(
e.g., sulfa-methoxypyridazine);
(4) electrolytes, vitamins, and other food
supplements and body nutrients not containing perocaine or other
drugs;
(8) sucralfate.
They may not be administered by any means within 24
hours of the scheduled post time of the race in which the horse is to compete.
In this regard, substances ingested by a horse shall be deemed administered at
the time of eating and drinking. It shall be part of the trainer's
responsibility to prevent such ingestion within such 24 hours.
(d) Nonsteroidal
anti-inflammatory drugs (NSAIDs). One clinical dose of either flunixin (e.g.,
Banamine), ketoprofen (e.g., Orudis) or phenylbutazone (e.g., Butazolidin) is
permitted to be administered in a single intravenous injection until 48 hours
before the scheduled post time of the race in which the horse is to
compete.
(e) The following
substances are permitted to be administered by any means until 48 hours before
the scheduled post time of the race in which the horse is to compete:
(1) aminophylline or theophylline;
(2) arsenic solution (
e.g.,
Fowlers Solution);
(3) aspirin or
sodium thiosalicylate;
(4)
chymotrypsin (
e.g., Kymar);
(5) diuretics (
e.g.,
furosemide (Lasix), except as otherwise provided pursuant to subdivision (b) of
this section, thiazide derivatives (
e.g., Di-uril));
(6) epinephrine (adrenaline);
(7) selenium/vitamin E
(
e.g., E-Se);
(8)
griseofulvin (
e.g., Fulvicin);
(9) hormones (
e.g.,
chorionic gonadatropin);
(10)
hyaluronic acid derivatives;
(12) iodine
injection (
e.g., Hypodermin, Harvey's Injectible
Blister);
(13) methenamine
(
e.g., Urotropin);
(14) orgotein (
e.g.,
Palosein);
(15) hydroxychloroquine
sulfate (
e.g., Rheaform);
(17) sulfonamide drugs
(
e.g., Sulfa);
(18)
biologics (
e.g., bacterins, antitoxins except
tetanus antitoxin); and
(19) an
oral or intravenous administration of dimethyl sulfoxide (i.e., DMSO).
None of these substances may be administered within 48
hours of the scheduled post time of the race in which the horse is to compete.
In this regard, substances ingested by a horse shall be deemed administered at
the time of eating and drinking. It shall be part of the trainer's
responsibility to prevent such ingestion within such 48 hours.
(f) The following substances may
be administered by any means except by joint injection until 72 hours before
the scheduled post time of the race in which the horse is to compete:
(3) ketamine hydrochloride;
(4) methocarbamol (
e.g.,
Robaxin);
(5) pentazocine
(
e.g., Talwin);
(6) trichloromethiazide; and
(7) vermifuges (worm medicines), except
phenothiazine;
None of these substances may be administered within 72
hours of the start the scheduled post time of the race in which the horse is to
compete. In this regard, substances ingested by a horse shall be deemed
administered at the time of eating and drinking. It shall be part of the
trainer's responsibility to prevent such ingestion within such 72 hours.
(g) The following
substances are permitted to be administered by any means except by joint
injection until 96 hours before the scheduled post time before the scheduled
post time of the race in which the horse is to compete:
(15) xylazine.
Such substances may be administered within 96 hours of
the scheduled post time of the race in which the horse is to compete. In this
regard, substances ingested by a horse shall be deemed administered at the time
of eating and drinking. It shall be part of the trainer's responsibility to
prevent such ingestion within such 96-hour period.
(h) No other drugs or medications (including
procaine) may be administered by any means within one week of the scheduled
post time of the race in which the horse is to compete. In this regard,
substances ingested by a horse shall be deemed administered at the time of
eating and drinking. It shall be part of the trainer's responsibility to
prevent such ingestion within such one-week period.
(i) In addition, a horse may not race for the
following periods of time:
(1) for at least
five days following a systemic administration of prednisolone or
dexamethasone;
(2) for at least 14
days following a joint injection;
(3) for at least 14 days following an
administration of clenbuterol or firocoxib.
In this regard, substances ingested by a horse shall be
deemed administered at the time of eating and drinking. It shall be part of the
trainer's responsibility to prevent such ingestion within such time periods.
The following corticosteroids may be administered only by means of a joint
injection: betamethasone, isoflupredone, any formulation of methylprednisolone
and any formulation of triamcinolone.
(j) The listing, reference to, or
denomination herein of any drug or other substance does not constitute
endorsement or recommendation by the commission for the use of such
drug.
(k) A horse may not race
after an administration of methylprednisolone acetate unless such horse
subsequently tests below the threshold set forth in section
4043.3 of this Part for such drug
in a test conducted by or for the commission at the sole expense of the trainer
of the horse; and is released to race by the stewards.
